CD8A and neoplasm: AntiPD-L1-SPIOs@PLGA@Au with local RT not only increased the number of CD8+ cells in tumor but also enhanced the proliferation of CD8+ cells in the tumor draining lymph nodes (TDLN) and elevated the level of serum IFN, indicating the activation of systemic antitumor immunity.